NSAID Selection for Elderly Patients with Knee Pain

Initial Treatment Approach

The American College of Rheumatology recommends starting with acetaminophen (paracetamol) up to 4,000 mg/day before considering any NSAID, as evidence demonstrates that paracetamol is comparable to ibuprofen for knee pain in the short term and can be used safely long-term in elderly patients without common contraindications 1, 2, 3, 4, 5

For patients aged ≥75 years, the American Geriatrics Society strongly recommends using topical NSAIDs over oral NSAIDs due to substantially greater risk for NSAID-associated cardiovascular, gastrointestinal, and renal adverse reactions 3
Topical diclofenac gel demonstrated equivalent efficacy to oral NSAIDs with an effect size of 0.91 compared to placebo, while minimizing systemic exposure 5

The treatment algorithm recommends initial therapy with acetaminophen up to 4,000 mg/day, and if inadequate, oral ibuprofen (up to 2,400 mg/day) for patients <75 years, and topical diclofenac gel 4g four times daily for patients ≥75 years 2, 3, 4
The American Heart Association recommends avoiding ibuprofen in patients taking low-dose aspirin for cardioprotection due to pharmacodynamic interaction that reduces aspirin's cardioprotective effect 3

Patients with increased GI risk, including those with GERD, should receive topical NSAIDs as a preferred option over oral NSAIDs according to the American Academy of Orthopaedic Surgeons guidelines 6, 7
The evidence demonstrates that topical NSAIDs have statistically significant effects on pain relief, stiffness, and function while having a reduced relative risk for adverse GI events compared with oral NSAIDs 6, 7

The American Academy of Orthopaedic Surgeons suggests starting with acetaminophen ≤4g/day, but for patients with GERD, topical diclofenac is recommended as first-line therapy due to increased GI risk 6, 7
Topical NSAIDs are specifically recommended for patients with increased GI risk, which includes GERD patients, according to the American Academy of Orthopaedic Surgeons guidelines 6, 7

Elderly patients (≥75 years) have a markedly increased risk of NSAID‑related gastrointestinal bleeding, cardiovascular events, and nephrotoxicity, with risk rising steeply with advancing age. 8

Topical non‑steroidal anti‑inflammatory drugs are preferred over oral NSAIDs for knee osteoarthritis in patients ≥75 years because they provide comparable pain relief while minimizing systemic exposure and associated adverse events. (Evidence from pooled trials in older adults.) 8

Acetaminophen up to 4 g per day should be tried before any NSAID in older adults, as it offers similar analgesic efficacy without the cardiovascular, gastrointestinal, or renal hazards linked to NSAIDs. [9][8]

If oral NSAID therapy is unavoidable, prescribe the lowest effective dose for the shortest possible duration and always co‑prescribe a proton‑pump inhibitor to mitigate gastrointestinal risk. 9
Both selective COX‑2 inhibitors (except etoricoxib 60 mg) and non‑selective NSAIDs carry significant cardiovascular and renal risks in octogenarians and should be used with caution. 9
Rofecoxib should be avoided in older adults because it predisposes to fluid retention and heightened cardiovascular risk. 8

Prolonged NSAID courses should be avoided; regular reassessment is required because adverse‑event risk accumulates with longer exposure, especially in the elderly. [9][8]

Topical NSAID therapy should be combined with non‑pharmacologic measures such as exercise programs, weight‑management strategies, and appropriate assistive devices to optimize functional outcomes. 9